Medically reviewed by Marla Anderson, MD Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood ...

Throughout my experience with multiple myeloma, I was humbled by the unexpected support and kindness shown to me.

The off-the-shelf chimeric antigen receptor T-cell therapy P-BCMA-ALLO1 was shown to be safe and elicited strong anti-tumor ...

Researchers sought to determine whether teclistamab would lead to a clinical response in patients with relapsed/refractory multiple myeloma.

Linvoseltamab is an investigational B-cell maturation antigen CD3-targeted bispecific antibody. The BLA resubmission was needed as the original application could not be approved due to manufacturing ...

Researchers sought to identify prognostic factors for survival in patients with newly diagnosed multiple myeloma.

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

1 Multiple myeloma originates in blood plasma cells — a type of cell found in bone marrow that is responsible for making antibodies. When these plasma cells become cancerous, they multiply ...

A research team from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ), the Berlin Institute of Health ...

New research shows that maintaining a healthy weight following a monoclonal gammopathy of undetermined significance diagnosis ...

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate commission. Meanwhile, some people can have a series of less intense ...